Subtypes of Endothelin ETA and ETB Receptors Mediating Venous Smooth Muscle Contraction
Overview
Affiliations
In rabbit saphenous vein, endothelin (ET)-1 and ET-3 induced sustained contractions whereas the selective agonists of the ETB receptor, sarafotoxin S6c (STXc) and IRL 1620, induced transient contractions. In the presence of an ETA antagonist, BQ-123, contractions induced by ET-1, STXc and IRL 1620 did not change whereas ET-3 induced only transient contraction. The ETB antagonists, RES-701-1 and IRL 1038, only weakly antagonized the effects of these stimulants. In the muscle pretreated with STXc, neither STXc nor IRL 1620 was effective whereas ET-3 induced sustained contraction at higher concentrations than ET-1. In the muscle pretreated with STXc, BQ-123 weakly antagonized the effect of ET-1 and abolished the effect of ET-3. These results suggest that there are two types of ET receptors; less tachyphylactic and isopeptide-selective ETA receptor, and tachyphylactic and isopeptide-nonselective ETB receptor. The ETA receptors may be further classified as a BQ-123-sensitive ETA1 and a BQ-123-insensitive ETA2 subtypes. The ETB receptors may also be subclassified as the ETB1 and ETB2 subtypes based on the sensitivity to the ETB antagonists.
Young A, Zhu J, Bagher A, Denovan-Wright E, Howlett S, Kelly M Geroscience. 2021; 43(3):1447-1463.
PMID: 33403617 PMC: 8190196. DOI: 10.1007/s11357-020-00309-7.
Endothelin-3 at low concentrations attenuates inflammatory responses via the endothelin B2 receptor.
Sato A, Ebina K Inflamm Res. 2013; 62(4):417-24.
PMID: 23370722 DOI: 10.1007/s00011-013-0594-3.
Endothelin ET(B) receptors in arteries and veins: multiple actions in the vein.
Tykocki N, Gariepy C, Watts S J Pharmacol Exp Ther. 2009; 329(3):875-81.
PMID: 19297422 PMC: 2683769. DOI: 10.1124/jpet.108.145953.
Evidence for two endothelin Et(A) receptor subtypes in rabbit arteriolar smooth muscle.
Curtis T, Scholfield C Br J Pharmacol. 2001; 134(8):1787-95.
PMID: 11739256 PMC: 1572890. DOI: 10.1038/sj.bjp.0704393.
Adner M, Shankley N, Edvinsson L Br J Pharmacol. 2001; 133(6):927-35.
PMID: 11454667 PMC: 1572843. DOI: 10.1038/sj.bjp.0704135.